John C. Rotschafer

105 papers receiving 5.4k citations

Hit Papers

Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists 2020 · 702 citations
7020+6+12Years since publication4008001.2k

Peers

John C. Rotschafer
Comparison fields: 5 of 133
  • Clinical Biochemistry 1.7k
  • Applied Microbiology and Biotechnology 410
  • Pharmacology 3.4k
  • Molecular Medicine 985
  • Infectious Diseases 3.1k
Replace Ben M. Lomaestro with:
Ben M. Lomaestro United States
Manjunath P. Pai United States
Annie Wong‐Beringer United States
Michael Neely United States
Richard Quintiliani United States
Stephen H. Zinner United States
Catherine Liu United States
Keith A. Rodvold United States
Michael Barza United States
Christian Joukhadar Austria
John C. Rotschafer relative to Ben M. Lomaestro United States Ben M. Lomaestro's profile →
Citations per field
00.5×1.5×1.9×
Ben M. Lomaestro · 1×
Citations per year

Countries citing papers authored by John C. Rotschafer

Since Specialization
Citations

This map shows the geographic impact of John C. Rotschafer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Rotschafer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Rotschafer more than expected).

Fields of papers citing papers by John C. Rotschafer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Rotschafer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Rotschafer. The network helps show where John C. Rotschafer may publish in the future.

Co-authors

The 25 scholars most cited alongside John C. Rotschafer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John C. Rotschafer Line = papers co-authored together John C. Rotschafer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
Hit paper breakdown →
20081392
2
Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
Hit paper breakdown →
2020702
3 2009319
4 2020290
5 1988192
6 1990188
7 2004151
8 1982149
9 1996132
10 2003119
11 1982114
12 199089
13 199686
14 200182
15 200382
16 199382
17 199374
18 199857
19 200553
20 202053

About John C. Rotschafer

John C. Rotschafer is a scholar working on Pharmacology, Infectious Diseases, Epidemiology, Molecular Medicine and Clinical Biochemistry, having authored 105 papers that have together received 5.7k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (72 papers), Antimicrobial Resistance in Staphylococcus (32 papers), Antibiotic Resistance in Bacteria (31 papers), Bacterial Identification and Susceptibility Testing (28 papers), Pneumonia and Respiratory Infections (27 papers), Antibiotic Use and Resistance (9 papers), Analytical Methods in Pharmaceuticals (5 papers) and Antifungal resistance and susceptibility (5 papers). The work is most often cited by research in Clinical Biochemistry (1.7k citations), Applied Microbiology and Biotechnology (410 citations), Pharmacology (3.4k citations), Molecular Medicine (985 citations) and Infectious Diseases (3.1k citations). John C. Rotschafer has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Michael J. Rybak, Donald P. Levine, Robert C. Moellering, William A. Craig, Ben M. Lomaestro, J. R. Dalovisio, Marianne Billeter, Keith A. Rodvold, Kyle Vance‐Bryan and David R.P. Guay. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Therapeutic Drug Monitoring, Diagnostic Microbiology and Infectious Disease and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact